Mj. Tolentino et al., INTRAVITREOUS INJECTIONS OF VASCULAR ENDOTHELIAL GROWTH-FACTOR PRODUCE RETINAL ISCHEMIA AND MICROANGIOPATHY IN AN ADULT PRIMATE, Ophthalmology, 103(11), 1996, pp. 1820-1828
Purpose: The purpose of the study is to determine the effect of exogen
ous vascular endothelial growth factor (VEGF) on the primate retina an
d its vasculature. Methods: Ten eyes of five animals were studied. Phy
siologlcally relevant amounts of the 165 amino acid isoform of human r
ecombinant VEGF were injected into the vitreous of six healthy cynomol
gus monkey eyes. inactivated human recombinant VEGF or vehicle was inj
ected into four contralateral control subject eyes. Eyes were assessed
by slit-lamp biomicroscopy, tonometry, fundus color photography, fund
us fluorescein angiography, light microscopy, and immunostaining with
antibodies against proliferating cell nuclear antigen and factor VIII
antigen, Results: Ail six bioactive VEGF-injected eyes developed dilat
ed, tortuous retinal vessels that leaked fluorescein. Eyes receiving m
ultiple injections of VEGF developed progressively dilated and tortuou
s vessels, Venous beading, edema, microaneurysms, intraretinal hemorrh
ages and capillary closure with ischemia. The severity of the retinopa
thy correlated with the number of VEGF injections. None of the four co
ntrol eyes exhibited any abnormal retinal vascular changes. The endoth
elial cells of retinal blood vessels were proliferating cell nuclear a
ntigen positive only in the bioactive VEGF-injected eyes. Conclusion:
Vascular endothelial growth factor is sufficient to produce many of th
e vascular abnormalities common to diabetic retinopathy and other isch
emic retinopathies, such as hemorrhage, edema, venous beading, capilla
ry occlusion with ischemia, microaneurysm formation, and intraretinal
vascular proliferation.